UFPT
UFP Technologies, Inc.
NASDAQ · USHealthcareMedical - Devices
$245.61+1.47%
Price as of Jul 20, 2026
UFPT financials
UFP Technologies, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $602.8M | $504.4M | $400.1M | $353.8M |
| Cost of revenue | $432.4M | $357.7M | $287.8M | $263.5M |
| Gross profit | $170.4M | $146.7M | $112.2M | $90.3M |
| Operating expenses | $78.1M | $65.8M | $54.6M | $34.9M |
| Operating income | $92.3M | $80.9M | $57.7M | $55.4M |
| Net income | $68.3M | $59.0M | $44.9M | $41.8M |
| EBITDA | $115.7M | $95.8M | $69.0M | $67.4M |
| Basic EPS | $8.87 | $7.69 | $5.89 | $5.52 |
| Diluted EPS | $8.77 | $7.58 | $5.83 | $5.45 |
| Balance sheet | ||||
| Cash & equivalents | $20.3M | $13.4M | $5.3M | $4.5M |
| Total assets | $665.7M | $629.0M | $404.1M | $378.2M |
| Total liabilities | $241.9M | $286.2M | $118.0M | $140.6M |
| Stockholders’ equity | $423.9M | $342.8M | $286.1M | $237.5M |
| Total debt | $154.5M | $206.0M | $46.0M | $68.4M |
| Net debt | $134.2M | $192.6M | $40.8M | $63.9M |
| Cash flow | ||||
| Operating cash flow | $91.9M | $66.6M | $41.3M | $17.7M |
| Capital expenditure | -$12.9M | -$9.7M | -$10.5M | -$13.8M |
| Free cash flow | $79.0M | $56.9M | $30.8M | $4.0M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |